UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus

Endocrine Journal, 2010, Vol.57(5), pp.383-394

2010

Volltextzugriff (PDF)

Addition of sitagliptin to ongoing glimepiride therapy in Japanese patients with type 2 diabetes over 52 weeks leads to improved glycemic control

Diabetology international, 2011-03, Vol.2 (1), p.32-44

2011

Volltextzugriff (PDF)

Quantitative analysis of vascular endothelial growth factor in primary breast cancer

Cancer, 1996-03, Vol.77 (6), p.1101-1106

1996

Volltextzugriff (PDF)

Expression of platelet‐derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer

International journal of cancer, 1995-04, Vol.64 (2), p.79-82

1995

Volltextzugriff (PDF)

Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study

Journal of bone and mineral metabolism, 2005-08, Vol.23 (5), p.382-388

2005

Volltextzugriff (PDF)

Long-term safety, tolerability, and efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes

Diabetology international, 2011-06, Vol.2 (2), p.94-105

2011

Volltextzugriff (PDF)

Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus

ENDOCRINE JOURNAL, 2010, Vol.57 (5), p.383-394

2010

Volltextzugriff (PDF)

An autopsy case of combined drug intoxication involving verapamil, metoprolol and digoxin

Forensic science international, 2003-04, Vol.133 (1), p.107-112

2003

Volltextzugriff (PDF)

Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study

Journal of bone and mineral metabolism, 2005-09, Vol.23 (5), p.382

2005

Volltextzugriff (PDF)

Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks

Journal of diabetes investigation, 2013-03, Vol.4 (2), p.174-181

2013

Volltextzugriff (PDF)

Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in J apanese patients with type 2 diabetes over 52 weeks

Journal of diabetes investigation, 2013-03, Vol.4 (2), p.174-181

2013

Volltextzugriff (PDF)

Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes

Journal of diabetes investigation, 2011-10, Vol.2 (5), p.381-390

2011

Volltextzugriff (PDF)

Increased Endothelium-Dependent Vascular Relaxation in Ethanol-Fed Rats

Alcoholism, clinical and experimental research, 1994-08, Vol.18 (4), p.1018-1023

1994

Volltextzugriff (PDF)

Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients

Clinical cancer research, 1996-05, Vol.2 (5), p.821-826

1996

Volltextzugriff (PDF)

Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer

Cancer research (Chicago, Ill.), 1998-10, Vol.58 (19), p.4461-4467

1998

Volltextzugriff (PDF)

Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes: Sitagliptin in Japanese patients with T2DM

Journal of diabetes investigation, 2011-10, Vol.2 (5), p.381-390

2011

Volltextzugriff (PDF)

Development of Tolerance to Inhibitory Effect of Ethanol on Endothelium-dependent Vascular Relaxation in Ethanol-fed Rats

Alcoholism, clinical and experimental research, 1991-02, Vol.15 (1), p.112-115

1991

Volltextzugriff (PDF)

Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer

Clinical cancer research, 1998-03, Vol.4 (3), p.659-664

1998

Volltextzugriff (PDF)

Serum concentrations of hepatocyte growth factor in breast cancer patients

Clinical cancer research, 1995-09, Vol.1 (9), p.1031-1034

1995

Volltextzugriff (PDF)

Heparin-associated thrombosis despite normal platelet counts

The Lancet (British edition), 1994-08, Vol.344 (8920), p.469-470

1994

Volltextzugriff (PDF)

Pharmacological and clinical profile of once weekly alendronate for the treatment of osteoporosis (Fosamac 35 mg/Bonalon 35 mg)

Folia Pharmacologica Japonica, 2007, Vol.130(4), pp.305-312

2007

Volltextzugriff (PDF)

Pharmacological and clinical profile of finasteride (PROPECIA®)

Folia Pharmacologica Japonica, 2006, Vol.127(6), pp.495-502

2006

Volltextzugriff (PDF)

An autopsy case of imipramine poisoning

The American journal of forensic medicine and pathology, 2005-09, Vol.26 (3), p.271-274

2005

Volltextzugriff (PDF)

DIFFERENT BLOOD ACETALDEHYDE CONCENTRATION FOLLOWING ETHANOL ADMINISTRATION IN A NEWLY DEVELOPED HIGH ALCOHOL PREFERENCE AND LOW ALCOHOL PREFERENCE RAT MODEL SYSTEM

Alcohol and alcoholism (Oxford), 2002-01, Vol.37 (1), p.9-12

2002

Volltextzugriff (PDF)

Investigation of the mechanism of enhancement of invasion and tumour growth by tissue factor in human cancer

Taniguchi, Tadaaki

1999

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(118)

Publikationsform

Sprache

Englisch
(115)
Japanisch
(50)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus

Addition of sitagliptin to ongoing glimepiride therapy in Japanese patients with type 2 diabetes over 52 weeks leads to improved glycemic control

Quantitative analysis of vascular endothelial growth factor in primary breast cancer

Expression of platelet‐derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer

Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study

Long-term safety, tolerability, and efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes

Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus

An autopsy case of combined drug intoxication involving verapamil, metoprolol and digoxin

Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study

Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks

Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in J apanese patients with type 2 diabetes over 52 weeks

Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes

Increased Endothelium-Dependent Vascular Relaxation in Ethanol-Fed Rats

Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients

Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer

Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes: Sitagliptin in Japanese patients with T2DM

Development of Tolerance to Inhibitory Effect of Ethanol on Endothelium-dependent Vascular Relaxation in Ethanol-fed Rats

Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer

Serum concentrations of hepatocyte growth factor in breast cancer patients

Heparin-associated thrombosis despite normal platelet counts

Pharmacological and clinical profile of once weekly alendronate for the treatment of osteoporosis (Fosamac 35 mg/Bonalon 35 mg)

Pharmacological and clinical profile of finasteride (PROPECIA®)

An autopsy case of imipramine poisoning

DIFFERENT BLOOD ACETALDEHYDE CONCENTRATION FOLLOWING ETHANOL ADMINISTRATION IN A NEWLY DEVELOPED HIGH ALCOHOL PREFERENCE AND LOW ALCOHOL PREFERENCE RAT MODEL SYSTEM

Investigation of the mechanism of enhancement of invasion and tumour growth by tissue factor in human cancer

Suchergebnisse filtern